MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025)

MDxHealth's (MDXH) quarterly Non-Current Deferred Tax Liability came in at $1.6 million in Q4 2025, down 99.9% quarter-over-quarter from $1.6 billion in Q2 2025.

MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

MDxHealth has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $1.6 million for Q4 2025.

  • Non-Current Deferred Tax Liability for Q4 2025 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY), and the FY2025 annual result was $1.6 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability came in at $1.6 million for Q4 2025 at MDxHealth, down from $1.6 billion in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.6 billion in Q2 2025 to a low of $129000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 MDxHealth 6,270.00 -43.15 Mn 16.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.60 Mn
Dec 31, 2025 1.60 Mn
Jun 30, 2025 1.57 Bn
Jun 30, 2025 1.57 Bn
Jun 30, 2022 129,000.00
Jun 30, 2022 129,000.00